Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia

Inclusion Criteria: * Patients with traumatic medullar injury (levels A, B, C or D of the ASIA scale) and associated syringomyelia in at least three spinal segments, and with neurological deficit clinically stable at least 6 months prior to treatment. * Previous studies in Neurophysiology, MR, Urology (if data on neurogenic bowel exists), defecatory function (if data on neurogenic intestine exists) * Age between 18 and 70 years old. * Presence of syringomyelia based on a neuro-image (MR) * Patients will compromise to use anticonceptive measures from the cell extraction until 6 months after the administration of the treatment. * Patients will compromise to a clinical follow-up and to perform physical therapy, one hour daily five days per week during the treatment period. * Patients should sign an written informed consent. * Haematological and creatinin parameters, SGOT and SGPT into the normal ranges. Exclusion Criteria: * Patients under 18 or above 70 years old * Pregnancy or breastfeeding * Neoplasia in the last 5 years * Patients with systemic diseases that increase the risk of the surgical intervention * Genetics alterations that could conduct to cellular transformation during the cellular expansion phase. * Patients not really sure of their cooperation to follow the physical therapy or clinical controls during the study. * Additional neurodegenerative diseases * Drug consuming, psychiatric disease or allergy to proteins used during cellular expansion * HIV or syphilis …